Aspire Health

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• TirzepatideType not stated
• SemaglutideType not stated

What they publish

Aspire Health publishes 1 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

A $100 figure appears on the page we captured, without a clear statement of what it covers

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• GLP-1s sit alongside a broader peptide offering. Peptides sold outside approved indications are a separate and considerably less regulated category.
• The $100 figure on the page was not clearly tied to a specific service.
• Medication regulatory status not stated.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Establish exactly what the $100 covers and the full monthly cost.
• Treat any peptide offering as a separate decision with its own evidence question.
• Ask whether the GLP-1 is FDA-approved or compounded.